Coffee Cuts Liver Cancer Risk 47% in 355,000-Adult Study, With Decaf Also Showing Benefits
Updated
Updated · Women's Health · Jul 25
Coffee Cuts Liver Cancer Risk 47% in 355,000-Adult Study, With Decaf Also Showing Benefits
3 articles · Updated · Women's Health · Jul 25
Summary
Nearly 355,000 UK Biobank participants tracked for about 13 years showed coffee drinkers had lower rates of liver disease, with five or more cups a day linked to a 47% lower liver cancer risk.
That higher-intake group also showed a 32% lower cirrhosis risk and a 42% lower risk of liver-related death versus non-drinkers, while smaller daily amounts still showed benefits.
Regular and decaf coffee both appeared protective, and coffee drinkers had lower markers of liver inflammation plus protein patterns suggesting healthier liver function.
Researchers said coffee’s polyphenols, chlorogenic acids and other compounds—not just caffeine—may drive antioxidant, anti-inflammatory and anti-scarring effects, though experts said more study is needed before treating coffee as a prevention strategy.